As of 30 Sep 2025, 23 institutional investors reported holding $119,255,386 in principal (par value) of CYTOKINETICS INC - NOTE 3.500% 7/0.
| Period | Principal | Value | Change | Price (% of par) (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | $6,000 | $853,000 | +$720,782 | 14216.67% | 1 |
| 2025 Q3 | $119,255,386 | $154,950,502 | -$378,018,070 | 129.97% | 23 |
| 2025 Q2 | $510,100,386 | $543,159,005 | +$17,771,762 | 106.39% | 41 |
| 2025 Q1 | $492,027,386 | $565,173,551 | +$15,594,304 | 114.75% | 43 |
| 2024 Q4 | $478,156,210 | $571,817,652 | -$15,817,848 | 119.26% | 44 |
| 2024 Q3 | $486,540,210 | $630,302,550 | -$54,080,884 | 129.45% | 45 |
| 2024 Q2 | $526,452,901 | $690,851,226 | -$37,380,306 | 130.7% | 50 |
| 2024 Q1 | $537,561,750 | $853,726,217 | -$21,056,135 | 158.76% | 46 |
| 2023 Q4 | $534,870,586 | $948,104,993 | +$49,778,015 | 176.23% | 54 |
| 2023 Q3 | $517,724,391 | $441,939,967 | +$441,940,003 | 85.31% | 45 |